Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Meropenem-induced valproic acid elimination: a case report of clinically relevant drug interaction

M. Šíma, J. Hartinger, J. Rulíšek, R. Šachl, O. Slanař

. 2017 ; 118 (2-3) : 105-109.

Jazyk angličtina Země Česko

Typ dokumentu kazuistiky, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18016033

We present two case reports of drug interaction between valproic acid and meropenem. In comparison with expected population-kinetic based serum levels, we observed 90.8 and 93.5% decrease in valproic acid serum levels during concomitant administration with meropenem. If carbapenems need to be administered to valproic acid treated patient, other anticonvulsant addition seems to be the appropriate as most probably the valproic acid dose escalation would not be sufficient to achieve therapeutic serum concentration.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18016033
003      
CZ-PrNML
005      
20180601120838.0
007      
ta
008      
180514s2017 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.14712/23362936.2017.11 $2 doi
035    __
$a (PubMed)28922108
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Šíma, Martin $u Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $7 xx0222901
245    10
$a Meropenem-induced valproic acid elimination: a case report of clinically relevant drug interaction / $c M. Šíma, J. Hartinger, J. Rulíšek, R. Šachl, O. Slanař
520    9_
$a We present two case reports of drug interaction between valproic acid and meropenem. In comparison with expected population-kinetic based serum levels, we observed 90.8 and 93.5% decrease in valproic acid serum levels during concomitant administration with meropenem. If carbapenems need to be administered to valproic acid treated patient, other anticonvulsant addition seems to be the appropriate as most probably the valproic acid dose escalation would not be sufficient to achieve therapeutic serum concentration.
650    _2
$a antibakteriální látky $x škodlivé účinky $7 D000900
650    _2
$a antikonvulziva $x škodlivé účinky $x krev $7 D000927
650    _2
$a lékové interakce $7 D004347
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a thienamyciny $x škodlivé účinky $7 D013845
650    _2
$a kyselina valproová $x škodlivé účinky $x krev $7 D014635
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hartinger, Jan $u Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $7 xx0224709
700    1_
$a Rulíšek, Jan $u Department of Anesthesiology and Intensive Care, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $7 xx0224602
700    1_
$a Šachl, Robert $u Department of Anesthesiology and Intensive Care, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic; Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $7 xx0210155
700    1_
$a Slanař, Ondřej $u Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $7 xx0058262
773    0_
$w MED00013414 $t Prague medical report $x 1214-6994 $g Roč. 118, č. 2-3 (2017), s. 105-109
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28922108 $y Pubmed
856    41
$u https://pmr.lf1.cuni.cz/media/pdf/pmr_2017118020105.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 7 $c 1071 $y 4 $z 0
990    __
$a 20180514 $b ABA008
991    __
$a 20180601121035 $b ABA008
999    __
$a ok $b bmc $g 1304744 $s 1012873
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 118 $c 2-3 $d 105-109 $i 1214-6994 $m Prague Medical Report $n Prague Med. Rep. $x MED00013414
LZP    __
$b NLK118 $a Pubmed-20180514
Zpět

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace